AI based healthtech startup NIRAMAI Health Analytix has confirmed a $6 million round of series A funding by Japanese VC firm, Dream Incubator.
The early investors of the company including Ankur Capital, Axilor Ventures, pi Ventures and Binny Bansal also remained a part of the funding.
The funding as per the company will be utilized to scale up India operations, recruit new talents and garnering more regulatory approvals for overseas expansion. Eto Munehiko, Managing Director, Dream Incubator Advisory and Investment India will become a part of the Niramai board post this round of funding.
“NIRAMAI helps to bridge the gap in our healthcare delivery systems by providing an AI tool that is accurate, affordable and accessible to all. If institutionalised as a regular screening method, NIRAMAI Thermalytix has the potential to save many lives not just from breast cancer deaths but eventually other diseases as well,’’ said Dr Geetha Manjunath, CEO, NIRAMAI.
“We are excited about partnering with Niramai that is building a truly deep-tech solution out of India. We also believe in the potential of their technology to solve global health problems at scale. The disruptive AI-based technology is key to early detection of disease and saving lives especially where there is a shortage of skilled medical professionals and dense breast ratio is high. Dream Incubator would support Niramai’s international expansion including Japan,’’ said Munehiko.
NIRAMAI was incepted in the year July 2016 by serial intrapreneur Dr Geetha and Nidhi and previously secured a seed funding of $1mn in the year April 2017.
